April 09, 2026
An Irish entity of drugmaker Mallinckrodt waited too long to seek dismissal of a price-fixing lawsuit brought by states based on a lack of personal jurisdiction or proper service, a Connecticut federal judge has ruled, finding that the company first raised that argument more than five years after the complaint was filed.
March 02, 2026
Solar panel co. PosiGen was given the green light to wind down, fiber network Tilson's Chapter 11 case was dismissed, and Mallinckrodt's bankruptcy prevented antitrust payouts.
February 24, 2026
A Connecticut federal judge has ruled that drugmaker Mallinckrodt PLC shrugged off monetary claims brought by states in a sprawling generic drug antitrust enforcement action when the company emerged from bankruptcy in 2022.
October 30, 2024
The trustee overseeing a pool of funds to pay creditors of Mallinckrodt plc has reached a deal to slash more than $331 billion of purported claims from insurers down to $6.7 million in the drugmaker's first bankruptcy case.
April 03, 2024
A Delaware bankruptcy judge ruled an assignee of claims from insurance companies against the opioid trust established in Mallinckrodt PLC's Chapter 11 case can't collect on them because the bankruptcy plan specifically prevents that.
April 01, 2024
A Delaware bankruptcy judge approved a roughly $57.4 million settlement between drugmaker Mallinckrodt and the U.S. government to settle claims over the cleanup costs of a Superfund site in an Illinois federal wildlife refuge
February 15, 2024
A Delaware bankruptcy judge on Thursday considered whether a company that pursues claims on behalf of medical insurers and healthcare organizations can be paid from a specialized opioid trust created by the 2022 Chapter 11 plan of Irish pharmaceutical company Mallinckrodt PLC.
January 05, 2024
A healthcare recovery and data company shouldn't be able to transact claims made against an opioid trust in Mallinckrodt's Chapter 11 bankruptcy, a trustee in the case has argued, telling a Delaware federal court that the trust is limited only to insurers and other providers of healthcare benefits.
May 31, 2023
A Delaware bankruptcy judge on Wednesday denied drugmaker Mallinckrodt's request to be released from a lawsuit over nuclear waste it produced 80 years ago as a contractor on the Manhattan Project, saying the suit does not violate a provision in the company's Chapter 11 plan.
April 20, 2023
Local Texas governments can't draw from an opioid claims trust established in drugmaker Mallinckrodt's Chapter 11 plan to pay legal fees incurred in state multidistrict opioid litigation, a Delaware bankruptcy judge said Wednesday.